中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2013年
5期
347-351
,共5页
王淑莲%李晔雄%宋清坤%李静%范金虎%张斌%杨红健%谢小明%唐中华
王淑蓮%李曄雄%宋清坤%李靜%範金虎%張斌%楊紅健%謝小明%唐中華
왕숙련%리엽웅%송청곤%리정%범금호%장빈%양홍건%사소명%당중화
乳腺肿瘤/根治术后放射疗法%放疗部位%临床流行病学
乳腺腫瘤/根治術後放射療法%放療部位%臨床流行病學
유선종류/근치술후방사요법%방료부위%림상류행병학
Breast neoplasms/postmastectomy radiotherapy%Radiotherapy target%Clinical epidemiology
目的 了解中国乳腺癌根治术后放疗部位变化.方法 随机纳入国内7家医院1999-2008年间乳腺癌根治术后放疗并有详细放疗部位资料的乳腺癌患者资料,分析放疗部位随治疗年代变化情况及不同医院间差别,以及放疗部位与临床病理因素的关系.采用SAS统计软件行Cochran-Armitage趋势检验和x2检验.结果 661例患者中90.2%(596例)、91.5%(606例)、29.6%(196例)和44.9%(297例)患者接受了胸壁、锁骨上下、腋窝和内乳放疗.1999-2008年间胸壁放疗的使用显著增加(P=0.000),腋窝、内乳区的放疗使用显著下降(P=0.027、0.000).胸壁、腋窝、内乳放疗以及锁骨上下区放疗的使用不同医院间不同(P =0.008、0.000、0.000、0000).腋窝放疗与腋窝淋巴结状态有关,内乳放疗与原发肿瘤部位有关.结论 国内乳腺癌根治术后放疗照射部位在不同年代和不同医院间有很大差别.多数患者接受了胸壁和锁骨上下区放疗,腋窝和内乳的放疗显著下降.
目的 瞭解中國乳腺癌根治術後放療部位變化.方法 隨機納入國內7傢醫院1999-2008年間乳腺癌根治術後放療併有詳細放療部位資料的乳腺癌患者資料,分析放療部位隨治療年代變化情況及不同醫院間差彆,以及放療部位與臨床病理因素的關繫.採用SAS統計軟件行Cochran-Armitage趨勢檢驗和x2檢驗.結果 661例患者中90.2%(596例)、91.5%(606例)、29.6%(196例)和44.9%(297例)患者接受瞭胸壁、鎖骨上下、腋窩和內乳放療.1999-2008年間胸壁放療的使用顯著增加(P=0.000),腋窩、內乳區的放療使用顯著下降(P=0.027、0.000).胸壁、腋窩、內乳放療以及鎖骨上下區放療的使用不同醫院間不同(P =0.008、0.000、0.000、0000).腋窩放療與腋窩淋巴結狀態有關,內乳放療與原髮腫瘤部位有關.結論 國內乳腺癌根治術後放療照射部位在不同年代和不同醫院間有很大差彆.多數患者接受瞭胸壁和鎖骨上下區放療,腋窩和內乳的放療顯著下降.
목적 료해중국유선암근치술후방료부위변화.방법 수궤납입국내7가의원1999-2008년간유선암근치술후방료병유상세방료부위자료적유선암환자자료,분석방료부위수치료년대변화정황급불동의원간차별,이급방료부위여림상병리인소적관계.채용SAS통계연건행Cochran-Armitage추세검험화x2검험.결과 661례환자중90.2%(596례)、91.5%(606례)、29.6%(196례)화44.9%(297례)환자접수료흉벽、쇄골상하、액와화내유방료.1999-2008년간흉벽방료적사용현저증가(P=0.000),액와、내유구적방료사용현저하강(P=0.027、0.000).흉벽、액와、내유방료이급쇄골상하구방료적사용불동의원간불동(P =0.008、0.000、0.000、0000).액와방료여액와림파결상태유관,내유방료여원발종류부위유관.결론 국내유선암근치술후방료조사부위재불동년대화불동의원간유흔대차별.다수환자접수료흉벽화쇄골상하구방료,액와화내유적방료현저하강.
Objective To investigate the changes in postmastectomy radiotherapy (PMRT) targets among breast cancer patients in China.Methods A multi-center retrospective epidemiological study was undertaken.Breast cancer patients who had received PMRT from 1999 to 2008 were randomly selected from seven hospitals in China,and the information on radiation targets,including the chest wall (CW),supraclavicular and infraclavicular regions (SCR/ICR),axilla,and internal mammary chain (IMC) was collected and analyzed.The Cochran-Armitage trend test and chi-square test were performed using SAS software to analyze the variation of PMRT targets over time,the differences in PMRT targets between hospitals,and the relationship between PMRT targets and clinicopathologic characteristics.Results Of 661included patients,596(90.2%),606(91.5%),196(29.6%),and 297(44.9%) had received PMRT to the CW,SCR/ICR,axilla,and IMC,respectively.From 1999 to 2008,there were an increase in use of PMRT to the CW (P =0.000) and decreases in use of PMRT to the axilla (P =0.027) and IMC (P =0.000).There were significant differences in use of PMRT to the CW (P =0.008),axilla (P =0.000),IMC (P =0.000),and SCR/ICR (P =0.000) between hospitals,but there were no significant differences in use of PMRT to the SCR/ICR from 1999 to 2008 (P =0.597).Use of PMRT to the axilla was associated with positive axillary nodes (P =0.007) and an axillary nodal ratio of 20% or more (P =0.007).Use of PMRT to the IMC was more frequent in patients with tumor located in the inner quadrant (P =0.015).Conclusions From 1999 to 2008,PMRT targets among breast cancer patients varied greatly over time and between different hospitals in China; most patients received PMRT to the CW and SCR/ICR,and use of PMRT to the axilla and IMC decreased significantly.